Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Kidney International|August 1, 1992
A comparison of the responses to recombinant human erythropoietin in normal and uremic subjectsJ W Eschbach, N R Haley, J C Egrie, et al.
The Journal of Clinical Investigation|August 1, 1984
The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivoJ W Eschbach, J Mladenovic, J F Garcia, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1985
Erythropoietin kinetics in normal and uremic sheepJ Mladenovic, J W Eschbach, J R Koup, et al.
Kidney International|May 1, 1988
The anemia of end-stage renal disease: hematopoietic progenitor cell responseG M Segal, J W Eschbach, J C Egrie, et al.
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
American Journal of Hypertension|December 1, 1990
Hypertension following erythropoietin therapy in anemic hemodialysis patientsF S Buckner, J W Eschbach, N R Haley, et al.
The New England Journal of Medicine|July 20, 1989
Treatment of the anemia of progressive renal failure with recombinant human erythropoietinJ W Eschbach, M R Kelly, N R Haley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1990
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patientsH T Robertson, N R Haley, M Guthrie, et al.
Seminars in Nephrology|August 6, 2000
Current concepts of anemia management in chronic renal failure: impact of NKF-DOQIJ W Eschbach
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1991
Erythropoietin 1991--an overviewJ W Eschbach
Pageof 17